| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |